 | • レポートコード：20QY06-05457 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、142ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、好酸球性食道炎薬のグローバル市場について種類別（ブデソニド、フルチカゾン、その他）、用途別（病院、診療所、ドラッグストア）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・好酸球性食道炎薬市場の概要 ・世界の主要地域別好酸球性食道炎薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の好酸球性食道炎薬市場規模2015-2026：種類別（ブデソニド、フルチカゾン、その他） ・世界の好酸球性食道炎薬市場規模2015-2026：用途別（病院、診療所、ドラッグストア） ・好酸球性食道炎薬の北米市場規模2015-2020 ・好酸球性食道炎薬のヨーロッパ市場規模2015-2020 ・好酸球性食道炎薬の中国市場規模2015-2020 ・好酸球性食道炎薬の日本市場規模2015-2020 ・好酸球性食道炎薬の東南アジア市場規模2015-2020 ・好酸球性食道炎薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （AstraZeneca、GSK、Bayer、Adare Pharmaceuticals、DBV Technologies、Dr. Falk Pharma、Quorum Innovations、Takeda、Calypso、Celgene、Regeneron） ・好酸球性食道炎薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・好酸球性食道炎薬の市場動向・機会・課題 ・調査の結論 |
Eosinophilic esophagitis (EoE, also spelled eosinophilic oesophagitis), also known as allergic oesophagitis, is an allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell. Symptoms are swallowing difficulty, food impaction, vomiting, and heartburn.
Eosinophilic esophagitis was first described in children but also occurs in adults. The condition is not well understood, but food allergy may play a significant role. The treatment may consist of removal of known or suspected triggers and medication to suppress the immune response.
This report studies the eosinophilic esophagitis drug market.
The classification of eosinophilic esophagitis drug includes budesonide, fluticasone and other types, and the proportion of budesonide in 2017 is about 52%.
Market Analysis and Insights: Global Eosinophilic Esophagitis Drug Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Eosinophilic Esophagitis Drug market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Eosinophilic Esophagitis Drug industry.
Based on our recent survey, we have several different scenarios about the Eosinophilic Esophagitis Drug YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 116.1 million in 2019. The market size of Eosinophilic Esophagitis Drug will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Eosinophilic Esophagitis Drug Scope and Market Size
The global Eosinophilic Esophagitis Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Eosinophilic Esophagitis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Eosinophilic Esophagitis Drug market is segmented into
Budesonide
Fluticasone
Others
Segment by Application, the Eosinophilic Esophagitis Drug market is segmented into
Hospitals
Clinics
Drugstore
The Eosinophilic Esophagitis Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Eosinophilic Esophagitis Drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Eosinophilic Esophagitis Drug Market Share Analysis
Eosinophilic Esophagitis Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Eosinophilic Esophagitis Drug business, the date to enter into the Eosinophilic Esophagitis Drug market, Eosinophilic Esophagitis Drug product introduction, recent developments, etc.
The major vendors covered:
AstraZeneca
GSK
Bayer
Adare Pharmaceuticals
DBV Technologies
Dr. Falk Pharma
Quorum Innovations
Takeda
Calypso
Celgene
Regeneron
1 Eosinophilic Esophagitis Drug Market Overview
1.1 Eosinophilic Esophagitis Drug Product Scope
1.2 Eosinophilic Esophagitis Drug Segment by Type
1.2.1 Global Eosinophilic Esophagitis Drug Sales by Type (2020-2026)
1.2.2 Budesonide
1.2.3 Fluticasone
1.2.4 Others
1.3 Eosinophilic Esophagitis Drug Segment by Application
1.3.1 Global Eosinophilic Esophagitis Drug Sales Comparison by Application (2020-2026)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Drugstore
1.4 Eosinophilic Esophagitis Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Eosinophilic Esophagitis Drug Sales Growth Rate (2015-2026)
1.4.2 Global Eosinophilic Esophagitis Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Eosinophilic Esophagitis Drug Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Eosinophilic Esophagitis Drug Industry Impact
1.5.1 How the Covid-19 is Affecting the Eosinophilic Esophagitis Drug Industry
1.5.1.1 Eosinophilic Esophagitis Drug Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Eosinophilic Esophagitis Drug Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Eosinophilic Esophagitis Drug Players to Combat Covid-19 Impact
2 Eosinophilic Esophagitis Drug Estimate and Forecast by Region
2.1 Global Eosinophilic Esophagitis Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Eosinophilic Esophagitis Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Eosinophilic Esophagitis Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Eosinophilic Esophagitis Drug Revenue Market Share by Region (2015-2020)
2.3 Global Eosinophilic Esophagitis Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Eosinophilic Esophagitis Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Eosinophilic Esophagitis Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Eosinophilic Esophagitis Drug Estimates and Projections (2015-2026)
2.4.2 Europe Eosinophilic Esophagitis Drug Estimates and Projections (2015-2026)
2.4.3 China Eosinophilic Esophagitis Drug Estimates and Projections (2015-2026)
2.4.4 Japan Eosinophilic Esophagitis Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Eosinophilic Esophagitis Drug Estimates and Projections (2015-2026)
2.4.6 India Eosinophilic Esophagitis Drug Estimates and Projections (2015-2026)
3 Global Eosinophilic Esophagitis Drug Competition Landscape by Players
3.1 Global Top Eosinophilic Esophagitis Drug Players by Sales (2015-2020)
3.2 Global Top Eosinophilic Esophagitis Drug Players by Revenue (2015-2020)
3.3 Global Eosinophilic Esophagitis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Eosinophilic Esophagitis Drug as of 2019)
3.4 Global Eosinophilic Esophagitis Drug Average Price by Company (2015-2020)
3.5 Manufacturers Eosinophilic Esophagitis Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Eosinophilic Esophagitis Drug Players (Opinion Leaders)
4 Global Eosinophilic Esophagitis Drug Market Size by Type
4.1 Global Eosinophilic Esophagitis Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Eosinophilic Esophagitis Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Eosinophilic Esophagitis Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Eosinophilic Esophagitis Drug Price by Type (2014-2020)
4.2 Global Eosinophilic Esophagitis Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Eosinophilic Esophagitis Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Eosinophilic Esophagitis Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Eosinophilic Esophagitis Drug Price Forecast by Type (2021-2026)
5 Global Eosinophilic Esophagitis Drug Market Size by Application
5.1 Global Eosinophilic Esophagitis Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Eosinophilic Esophagitis Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Eosinophilic Esophagitis Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Eosinophilic Esophagitis Drug Price by Application (2015-2020)
5.2 Global Eosinophilic Esophagitis Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Eosinophilic Esophagitis Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Eosinophilic Esophagitis Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Eosinophilic Esophagitis Drug Price Forecast by Application (2021-2026)
3 North America Eosinophilic Esophagitis Drug Market Facts & Figures
3.2 North America Eosinophilic Esophagitis Drug Sales Market Share by Company (2015-2020)
3.3 North America Eosinophilic Esophagitis Drug Sales Market Share by Type (2015-2020)
3.4 North America Eosinophilic Esophagitis Drug Sales Market Share by Application (2015-2020)
4 Europe Eosinophilic Esophagitis Drug Market Facts & Figures
4.2 Europe Eosinophilic Esophagitis Drug Sales Market Share by Company (2015-2020)
4.3 Europe Eosinophilic Esophagitis Drug Sales Market Share by Type (2015-2020)
4.4 Europe Eosinophilic Esophagitis Drug Sales Market Share by Application (2015-2020)
5 China Eosinophilic Esophagitis Drug Market Facts & Figures
5.2 China Eosinophilic Esophagitis Drug Sales Market Share by Company (2015-2020)
5.3 China Eosinophilic Esophagitis Drug Sales Market Share by Type (2015-2020)
5.4 China Eosinophilic Esophagitis Drug Sales Market Share by Application (2015-2020)
6 Japan Eosinophilic Esophagitis Drug Market Facts & Figures
6.2 Japan Eosinophilic Esophagitis Drug Sales Market Share by Company (2015-2020)
6.3 Japan Eosinophilic Esophagitis Drug Sales Market Share by Type (2015-2020)
6.4 Japan Eosinophilic Esophagitis Drug Sales Market Share by Application (2015-2020)
7 Southeast Asia Eosinophilic Esophagitis Drug Market Facts & Figures
7.2 Southeast Asia Eosinophilic Esophagitis Drug Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Eosinophilic Esophagitis Drug Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Eosinophilic Esophagitis Drug Sales Market Share by Application (2015-2020)
8 India Eosinophilic Esophagitis Drug Market Facts & Figures
8.2 India Eosinophilic Esophagitis Drug Sales Market Share by Company (2015-2020)
8.3 India Eosinophilic Esophagitis Drug Sales Market Share by Type (2015-2020)
8.4 India Eosinophilic Esophagitis Drug Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Eosinophilic Esophagitis Drug Business
12.1 AstraZeneca
12.1.1 AstraZeneca Eosinophilic Esophagitis Drug Corporation Information
12.1.2 AstraZeneca Eosinophilic Esophagitis Drug Business Overview and Total Revenue
12.1.3 AstraZeneca Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 AstraZeneca Eosinophilic Esophagitis Drug Products Offered
12.1.5 AstraZeneca Recent Development
12.2 GSK
12.2.1 GSK Eosinophilic Esophagitis Drug Corporation Information
12.2.2 GSK Eosinophilic Esophagitis Drug Business Overview and Total Revenue
12.2.3 GSK Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 GSK Eosinophilic Esophagitis Drug Products Offered
12.2.5 GSK Recent Development
12.3 Bayer
12.3.1 Bayer Eosinophilic Esophagitis Drug Corporation Information
12.3.2 Bayer Eosinophilic Esophagitis Drug Business Overview and Total Revenue
12.3.3 Bayer Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Bayer Eosinophilic Esophagitis Drug Products Offered
12.3.5 Bayer Recent Development
12.4 Adare Pharmaceuticals
12.4.1 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Corporation Information
12.4.2 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Business Overview and Total Revenue
12.4.3 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Products Offered
12.4.5 Adare Pharmaceuticals Recent Development
12.5 DBV Technologies
12.5.1 DBV Technologies Eosinophilic Esophagitis Drug Corporation Information
12.5.2 DBV Technologies Eosinophilic Esophagitis Drug Business Overview and Total Revenue
12.5.3 DBV Technologies Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 DBV Technologies Eosinophilic Esophagitis Drug Products Offered
12.5.5 DBV Technologies Recent Development
12.6 Dr. Falk Pharma
12.6.1 Dr. Falk Pharma Eosinophilic Esophagitis Drug Corporation Information
12.6.2 Dr. Falk Pharma Eosinophilic Esophagitis Drug Business Overview and Total Revenue
12.6.3 Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Dr. Falk Pharma Eosinophilic Esophagitis Drug Products Offered
12.6.5 Dr. Falk Pharma Recent Development
12.7 Quorum Innovations
12.7.1 Quorum Innovations Eosinophilic Esophagitis Drug Corporation Information
12.7.2 Quorum Innovations Eosinophilic Esophagitis Drug Business Overview and Total Revenue
12.7.3 Quorum Innovations Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Quorum Innovations Eosinophilic Esophagitis Drug Products Offered
12.7.5 Quorum Innovations Recent Development
12.8 Takeda
12.8.1 Takeda Eosinophilic Esophagitis Drug Corporation Information
12.8.2 Takeda Eosinophilic Esophagitis Drug Business Overview and Total Revenue
12.8.3 Takeda Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Takeda Eosinophilic Esophagitis Drug Products Offered
12.8.5 Takeda Recent Development
12.9 Calypso
12.9.1 Calypso Eosinophilic Esophagitis Drug Corporation Information
12.9.2 Calypso Eosinophilic Esophagitis Drug Business Overview and Total Revenue
12.9.3 Calypso Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Calypso Eosinophilic Esophagitis Drug Products Offered
12.9.5 Calypso Recent Development
12.10 Celgene
12.10.1 Celgene Eosinophilic Esophagitis Drug Corporation Information
12.10.2 Celgene Eosinophilic Esophagitis Drug Business Overview and Total Revenue
12.10.3 Celgene Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Celgene Eosinophilic Esophagitis Drug Products Offered
12.10.5 Celgene Recent Development
12.11 Regeneron
12.11.1 Regeneron Eosinophilic Esophagitis Drug Corporation Information
12.11.2 Regeneron Eosinophilic Esophagitis Drug Business Overview and Total Revenue
12.11.3 Regeneron Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Regeneron Eosinophilic Esophagitis Drug Products Offered
12.11.5 Regeneron Recent Development
13 Eosinophilic Esophagitis Drug Manufacturing Cost Analysis
13.1 Eosinophilic Esophagitis Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Eosinophilic Esophagitis Drug
13.4 Eosinophilic Esophagitis Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Eosinophilic Esophagitis Drug Distributors List
14.3 Eosinophilic Esophagitis Drug Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Eosinophilic Esophagitis Drug Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Eosinophilic Esophagitis Drug Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Eosinophilic Esophagitis Drug Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Eosinophilic Esophagitis Drug Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Eosinophilic Esophagitis Drug Players to Combat Covid-19 Impact
Table 8. Global Market Eosinophilic Esophagitis Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Eosinophilic Esophagitis Drug Sales (K Units) by Region (2015-2020)
Table 10. Global Eosinophilic Esophagitis Drug Sales Market Share by Region (2015-2020)
Table 11. Global Eosinophilic Esophagitis Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Eosinophilic Esophagitis Drug Revenue Share by Region (2015-2020)
Table 13. Global Eosinophilic Esophagitis Drug Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Eosinophilic Esophagitis Drug Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Eosinophilic Esophagitis Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Eosinophilic Esophagitis Drug Revenue Share Forecast by Region (2021-2026)
Table 17. Global Eosinophilic Esophagitis Drug (K Units) of Key Companies (2015-2020)
Table 18. Global Eosinophilic Esophagitis Drug Sales Share by Company (2015-2020)
Table 19. Global Eosinophilic Esophagitis Drug Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Eosinophilic Esophagitis Drug Revenue Share by Company (2015-2020)
Table 21. Global Eosinophilic Esophagitis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Eosinophilic Esophagitis Drug as of 2019)
Table 22. Global Eosinophilic Esophagitis Drug Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Eosinophilic Esophagitis Drug Manufacturing Sites and Area Served
Table 24. Manufacturers Eosinophilic Esophagitis Drug Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Eosinophilic Esophagitis Drug Players
Table 27. Global Eosinophilic Esophagitis Drug Sales (K Units) by Type (2015-2020)
Table 28. Global Eosinophilic Esophagitis Drug Sales Share by Type (2015-2020)
Table 29. Global Eosinophilic Esophagitis Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Eosinophilic Esophagitis Drug Price (K Units) by Type (2015-2020)
Table 31. Global Eosinophilic Esophagitis Drug Sales Share by Type (2021-2026)
Table 32. Global Eosinophilic Esophagitis Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Eosinophilic Esophagitis Drug Revenue Share by Type (2021-2026)
Table 34. Global Eosinophilic Esophagitis Drug Price (K Units) by Type (2021-2026)
Table 35. Global Eosinophilic Esophagitis Drug Sales (K Units) by Application (2015-2020)
Table 36. Global Eosinophilic Esophagitis Drug Sales Share by Application (2015-2020)
Table 37. Global Eosinophilic Esophagitis Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Eosinophilic Esophagitis Drug Price (K Units) by Application (2015-2020)
Table 39. Global Eosinophilic Esophagitis Drug Sales (K Units) by Application (2021-2026)
Table 40. Global Eosinophilic Esophagitis Drug Sales Share by Application (2021-2026)
Table 41. Global Eosinophilic Esophagitis Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Eosinophilic Esophagitis Drug Revenue Share by Application (2021-2026)
Table 43. Global Eosinophilic Esophagitis Drug Price (K Units) by Application (2021-2026)
Table 44. United States Eosinophilic Esophagitis Drug Sales (K Units) by Company (2015-2020)
Table 45. United States Eosinophilic Esophagitis Drug Sales Market Share by Company (2015-2020)
Table 46. United States Eosinophilic Esophagitis Drug Sales (K Units) by Type (2015-2020)
Table 47. United States Eosinophilic Esophagitis Drug Sales Market Share by Type (2015-2020)
Table 48. United States Eosinophilic Esophagitis Drug Sales (K Units) by Application (2015-2020)
Table 49. United States Eosinophilic Esophagitis Drug Sales Market Share by Application (2015-2020)
Table 50. Europe Eosinophilic Esophagitis Drug Sales (K Units) by Company (2015-2020)
Table 51. Europe Eosinophilic Esophagitis Drug Sales Market Share by Company (2015-2020)
Table 52. Europe Eosinophilic Esophagitis Drug Sales (K Units) by Type (2015-2020)
Table 53. Europe Eosinophilic Esophagitis Drug Sales Market Share by Type (2015-2020)
Table 54. Europe Eosinophilic Esophagitis Drug Sales (K Units) by Application (2015-2020)
Table 55. Europe Eosinophilic Esophagitis Drug Sales Market Share by Type (2015-2020)
Table 56. China Eosinophilic Esophagitis Drug Sales (K Units) by Company (2015-2020)
Table 57. China Eosinophilic Esophagitis Drug Sales Market Share by Company (2015-2020)
Table 58. China Eosinophilic Esophagitis Drug Sales (K Units) by Type (2015-2020)
Table 59. China Eosinophilic Esophagitis Drug Sales Market Share by Type (2015-2020)
Table 60. China Eosinophilic Esophagitis Drug Sales (K Units) by Application (2015-2020)
Table 61. China Eosinophilic Esophagitis Drug Sales Market Share by Application (2015-2020)
Table 62. Japan Eosinophilic Esophagitis Drug Sales (K Units) by Company (2015-2020)
Table 63. Japan Eosinophilic Esophagitis Drug Sales Market Share by Company (2015-2020)
Table 64. Japan Eosinophilic Esophagitis Drug Sales (K Units) by Type (2015-2020)
Table 65. Japan Eosinophilic Esophagitis Drug Sales Market Share by Type (2015-2020)
Table 66. Japan Eosinophilic Esophagitis Drug Sales (K Units) by Application (2015-2020)
Table 67. Japan Eosinophilic Esophagitis Drug Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Eosinophilic Esophagitis Drug Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Eosinophilic Esophagitis Drug Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Eosinophilic Esophagitis Drug Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Eosinophilic Esophagitis Drug Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Eosinophilic Esophagitis Drug Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Eosinophilic Esophagitis Drug Sales Market Share by Application (2015-2020)
Table 74. India Eosinophilic Esophagitis Drug Sales (K Units) by Company (2015-2020)
Table 75. India Eosinophilic Esophagitis Drug Sales Market Share by Company (2015-2020)
Table 76. India Eosinophilic Esophagitis Drug Sales (K Units) by Type (2015-2020)
Table 77. India Eosinophilic Esophagitis Drug Sales Market Share by Type (2015-2020)
Table 78. India Eosinophilic Esophagitis Drug Sales (K Units) by Application (2015-2020)
Table 79. India Eosinophilic Esophagitis Drug Sales Market Share by Application (2015-2020)
Table 80. AstraZeneca Corporation Information
Table 81. AstraZeneca Description and Business Overview
Table 82. AstraZeneca Eosinophilic Esophagitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. AstraZeneca Eosinophilic Esophagitis Drug Product
Table 84. AstraZeneca Recent Development
Table 85. GSK Corporation Information
Table 86. GSK Description and Business Overview
Table 87. GSK Eosinophilic Esophagitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. GSK Eosinophilic Esophagitis Drug Product
Table 89. GSK Recent Development
Table 90. Bayer Corporation Information
Table 91. Bayer Description and Business Overview
Table 92. Bayer Eosinophilic Esophagitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Bayer Eosinophilic Esophagitis Drug Product
Table 94. Bayer Recent Development
Table 95. Adare Pharmaceuticals Corporation Information
Table 96. Adare Pharmaceuticals Description and Business Overview
Table 97. Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Adare Pharmaceuticals Eosinophilic Esophagitis Drug Product
Table 99. Adare Pharmaceuticals Recent Development
Table 100. DBV Technologies Corporation Information
Table 101. DBV Technologies Description and Business Overview
Table 102. DBV Technologies Eosinophilic Esophagitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. DBV Technologies Eosinophilic Esophagitis Drug Product
Table 104. DBV Technologies Recent Development
Table 105. Dr. Falk Pharma Corporation Information
Table 106. Dr. Falk Pharma Description and Business Overview
Table 107. Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Dr. Falk Pharma Eosinophilic Esophagitis Drug Product
Table 109. Dr. Falk Pharma Recent Development
Table 110. Quorum Innovations Corporation Information
Table 111. Quorum Innovations Description and Business Overview
Table 112. Quorum Innovations Eosinophilic Esophagitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Quorum Innovations Eosinophilic Esophagitis Drug Product
Table 114. Quorum Innovations Recent Development
Table 115. Takeda Corporation Information
Table 116. Takeda Eosinophilic Esophagitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Takeda Description and Business Overview
Table 118. Takeda Eosinophilic Esophagitis Drug Product
Table 119. Takeda Recent Development
Table 120. Calypso Corporation Information
Table 121. Calypso Eosinophilic Esophagitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Calypso Description and Business Overview
Table 123. Calypso Eosinophilic Esophagitis Drug Product
Table 124. Calypso Recent Development
Table 125. Celgene Corporation Information
Table 126. Celgene Description and Business Overview
Table 127. Celgene Eosinophilic Esophagitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Celgene Eosinophilic Esophagitis Drug Product
Table 129. Celgene Recent Development
Table . Regeneron Corporation Information
Table . Regeneron Description and Business Overview
Table . Regeneron Eosinophilic Esophagitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Regeneron Eosinophilic Esophagitis Drug Product
Table . Regeneron Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Eosinophilic Esophagitis Drug Distributors List
Table 138. Eosinophilic Esophagitis Drug Customers List
Table 139. Market Key Trends
Table 140. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 141. Key Challenges
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Eosinophilic Esophagitis Drug Product Picture
Figure 2. Global Eosinophilic Esophagitis Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Eosinophilic Esophagitis Drug Market Share by Application in 2020 & 2026
Figure 6. Hospitals Examples
Figure 7. Clinics Examples
Figure 8. Drugstore Examples
Figure 9. Global Eosinophilic Esophagitis Drug Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Eosinophilic Esophagitis Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Eosinophilic Esophagitis Drug Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Eosinophilic Esophagitis Drug Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Eosinophilic Esophagitis Drug Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Eosinophilic Esophagitis Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Eosinophilic Esophagitis Drug Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Eosinophilic Esophagitis Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Eosinophilic Esophagitis Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Eosinophilic Esophagitis Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Eosinophilic Esophagitis Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Eosinophilic Esophagitis Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Eosinophilic Esophagitis Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Eosinophilic Esophagitis Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Eosinophilic Esophagitis Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Eosinophilic Esophagitis Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Eosinophilic Esophagitis Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Eosinophilic Esophagitis Drug Players Market Share by Revenue in Eosinophilic Esophagitis Drug 2015 & 2019
Figure 27. Eosinophilic Esophagitis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Eosinophilic Esophagitis Drug Revenue Share by Type (2015-2020)
Figure 29. Global Eosinophilic Esophagitis Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Eosinophilic Esophagitis Drug Revenue Share by Application (2015-2020)
Figure 31. Global Eosinophilic Esophagitis Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Eosinophilic Esophagitis Drug Sales Market Share by Type in 2019
Figure 33. United States Eosinophilic Esophagitis Drug Sales Market Share by Type in 2019
Figure 34. Europe Eosinophilic Esophagitis Drug Sales Market Share by Company in 2019
Figure 35. Europe Eosinophilic Esophagitis Drug Sales Market Share by Type in 2019
Figure 36. Europe Eosinophilic Esophagitis Drug Sales Market Share by Application in 2019
Figure 37. China Eosinophilic Esophagitis Drug Sales Market Share by Company in 2019
Figure 38. China Eosinophilic Esophagitis Drug Sales Market Share by Type in 2019
Figure 39. China Eosinophilic Esophagitis Drug Sales Market Share by Application in 2019
Figure 40. Japan Eosinophilic Esophagitis Drug Sales Market Share by Company in 2019
Figure 41. Japan Eosinophilic Esophagitis Drug Sales Market Share by Type in 2019
Figure 42. Japan Eosinophilic Esophagitis Drug Sales Market Share by Application in 2019
Figure 43. Southeast Asia Eosinophilic Esophagitis Drug Sales Market Share by Company in 2019
Figure 44. Southeast Asia Eosinophilic Esophagitis Drug Sales Market Share by Type in 2019
Figure 45. Southeast Asia Eosinophilic Esophagitis Drug Sales Market Share by Application in 2019
Figure 46. India Eosinophilic Esophagitis Drug Sales Market Share by Company in 2019
Figure 47. India Eosinophilic Esophagitis Drug Sales Market Share by Type in 2019
Figure 48. India Eosinophilic Esophagitis Drug Sales Market Share by Application in 2019
Figure 49. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Adare Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. DBV Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Dr. Falk Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Quorum Innovations Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Calypso Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Celgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Regeneron Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Key Raw Materials Price Trend
Figure 61. Manufacturing Cost Structure of Eosinophilic Esophagitis Drug
Figure 62. Manufacturing Process Analysis of Eosinophilic Esophagitis Drug
Figure 63. Eosinophilic Esophagitis Drug Industrial Chain Analysis
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Figure 66. Porter's Five Forces Analysis
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
象皮病薬の世界市場レポート2020 Market Analysis and Insights: Global Elephantiasis Drug Market The global Elephantiasis Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Elephantiasis Drug Scope and Market Size The global Elephantias…- 植物薬の世界市場レポート2020 Market Analysis and Insights: Global Botanical Drug Market The global Botanical Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Botanical Drug Scope and Market Size The global Botanical Drug market i…
- フィブリノーゲン欠乏症薬の世界市場レポート2020 Market Analysis and Insights: Global Fibrinogen Deficiency Drug Market The global Fibrinogen Deficiency Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Fibrinogen Deficiency Drug Scope and Market Siz…
- アレルギー鼻炎薬の世界市場レポート2020 Market Analysis and Insights: Global Allergy Rhinitis Drug Market The global Allergy Rhinitis Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Allergy Rhinitis Drug Scope and Market Size The global Al…
- 細菌性赤痢薬の世界市場レポート2020 Market Analysis and Insights: Global Bacillary Dysentery Drug Market The global Bacillary Dysentery Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Bacillary Dysentery Drug Scope and Market Size The …